United States · FDA National Drug Code directory
PEMAZYRE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50881-026_7ab778c9-5f92-4e53-bfe8-8db8d3bd3ef3
- Product NDC
- 50881-026
- Form
- TABLET
- Composition / generic term
- pemigatinib
- Labeler
- Incyte Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200417
- Source listing expiry
- 20271231
Source-listed ingredients
- PEMIGATINIB — 4.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET in 1 BOTTLE, PLASTIC (50881-026-01) · 50881-026-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →